W ANTHONY VERNON, a director at $NVCR, sold 999 shares of the company on 06-03-2025 for an estimated $17,329. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.6% of their shares of this class of stock. Following this trade, they now own 167,887 shares of this class of $NVCR stock.
$NVCR Insider Trading Activity
$NVCR insiders have traded $NVCR stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $NVCR stock by insiders over the last 6 months:
- FRANK X LEONARD (EVP, Pres., Novocure Oncology) has made 0 purchases and 6 sales selling 45,232 shares for an estimated $824,669.
- ASHLEY CORDOVA (Chief Executive Officer) has made 0 purchases and 3 sales selling 13,494 shares for an estimated $266,126.
- MUKUND PARAVASTHU (Chief Operating Officer) has made 0 purchases and 5 sales selling 4,766 shares for an estimated $108,197.
- URI WEINBERG (Chief Innovation Officer) has made 0 purchases and 2 sales selling 4,637 shares for an estimated $86,949.
- MICHAL NATH PURI (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 1,387 shares for an estimated $27,772.
- NICOLAS LEUPIN (Chief Medical Officer) has made 0 purchases and 2 sales selling 991 shares for an estimated $19,843.
- W ANTHONY VERNON sold 999 shares for an estimated $17,329
- DAVID HUNG sold 999 shares for an estimated $17,279
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NVCR Hedge Fund Activity
We have seen 112 institutional investors add shares of $NVCR stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOLEUS CAPITAL MANAGEMENT, L.P. added 2,781,710 shares (+101.5%) to their portfolio in Q1 2025, for an estimated $49,570,072
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,690,441 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,123,658
- MARSHALL WACE, LLP added 1,536,639 shares (+567.1%) to their portfolio in Q1 2025, for an estimated $27,382,906
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,201,784 shares (-71.4%) from their portfolio in Q1 2025, for an estimated $21,415,790
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,080,514 shares (+154.0%) to their portfolio in Q1 2025, for an estimated $19,254,759
- QUANTINNO CAPITAL MANAGEMENT LP added 693,613 shares (+235.4%) to their portfolio in Q1 2025, for an estimated $12,360,183
- FEDERATED HERMES, INC. removed 687,912 shares (-75.8%) from their portfolio in Q1 2025, for an estimated $12,258,591
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NVCR Analyst Ratings
Wall Street analysts have issued reports on $NVCR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI issued a "Outperform" rating on 01/02/2025
To track analyst ratings and price targets for $NVCR, check out Quiver Quantitative's $NVCR forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
